ALK and lung carcinoma: On the basis of these findings they also hypothesised that acquired resistance to ALK-specific TKIs was highly likely to involve reactivation of the Ras/ERK pathway and this was confirmed in experiments in which ELM4–ALK positive lung cancer cells were rendered drug resistant by chronic exposure to crizotinib.